- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Sustainable Track Record
Danish Pharmaceuticals & Biotech Sustainable Track Record
Results
2
0 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
Genmab
Market Cap: DKK 126.4b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,029.00
7D
3.7%
1Y
34.3%
ChemoMetec
Market Cap: DKK 13.5b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 781.00
7D
2.8%
1Y
62.7%